Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedFeb 29, 2024
DataAggregated Company Financials
Companies5
  • 7D2.5%
  • 3M0.6%
  • 1Y-12.6%
  • YTD-1.2%

The Biotech industry is up 2.5% in the last week, with Zealand Pharma up 39%. In contrast, the industry has lost 13% in the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 01 Mar 2024kr.176.9bkr.22.8bkr.4.3b22.9x41.4x7.8x
Sun, 28 Jan 2024kr.167.0bkr.23.3bkr.4.2b22.9x40.1x7.2x
Tue, 26 Dec 2023kr.175.3bkr.23.3bkr.4.2b25.7x42.1x7.5x
Thu, 23 Nov 2023kr.172.6bkr.23.3bkr.4.2b24.5x41.5x7.4x
Sat, 21 Oct 2023kr.162.9bkr.22.0bkr.4.7b18.9x34.4x7.4x
Mon, 18 Sep 2023kr.203.4bkr.22.0bkr.4.7b23.5x43x9.2x
Wed, 16 Aug 2023kr.191.7bkr.20.6bkr.3.9b37.4x49.5x9.3x
Fri, 14 Jul 2023kr.198.0bkr.19.5bkr.4.4b40.9x44.9x10.1x
Sun, 11 Jun 2023kr.206.9bkr.19.5bkr.4.4b43.5x47x10.6x
Tue, 09 May 2023kr.207.5bkr.17.9bkr.4.1b32.4x50.7x11.6x
Thu, 06 Apr 2023kr.199.2bkr.17.9bkr.3.5b31x56.3x11.1x
Sat, 04 Mar 2023kr.197.5bkr.17.9bkr.3.5b30.4x55.7x11x
Mon, 30 Jan 2023kr.203.0bkr.14.7bkr.3.3b30.7x62x13.8x
Wed, 28 Dec 2022kr.222.6bkr.14.7bkr.3.3b34.8x68x15.1x
Fri, 25 Nov 2022kr.236.1bkr.14.7bkr.3.3b37x72.1x16x
Sun, 23 Oct 2022kr.202.7bkr.12.4bkr.1.5b44.8x133.5x16.3x
Tue, 20 Sep 2022kr.191.3bkr.12.4bkr.1.5b42.7x128.5x15.4x
Thu, 18 Aug 2022kr.205.7bkr.12.2bkr.1.6b43.8x130.2x16.8x
Sat, 16 Jul 2022kr.188.1bkr.11.1bkr.130.5m69.8x1441.3x17x
Mon, 13 Jun 2022kr.153.4bkr.11.1bkr.130.5m56.9x1175.9x13.9x
Wed, 11 May 2022kr.149.0bkr.10.7bkr.622.4m45.3x239.4x13.9x
Fri, 08 Apr 2022kr.188.6bkr.10.7bkr.622.4m57x303.1x17.6x
Sun, 06 Mar 2022kr.153.9bkr.10.7bkr.525.4m46.3x292.9x14.4x
Tue, 01 Feb 2022kr.166.2bkr.9.8bkr.117.9m50.8x1409.5x16.9x
Thu, 30 Dec 2021kr.196.1bkr.9.8bkr.117.9m59.2x1662.9x20x
Sat, 27 Nov 2021kr.197.6bkr.9.8bkr.117.9m59.1x1675.2x20.1x
Mon, 25 Oct 2021kr.226.3bkr.9.3b-kr.169,922,000.0077.8x-1332x24.3x
Wed, 22 Sep 2021kr.216.4bkr.9.3b-kr.169,922,000.0073.3x-1273.5x23.3x
Fri, 20 Aug 2021kr.226.4bkr.9.3b-kr.169,922,000.0079.2x-1332.6x24.3x
Fri, 04 Jun 2021kr.187.9bkr.13.2bkr.3.5b28.8x53.6x14.2x
Mon, 08 Mar 2021kr.161.0bkr.12.3bkr.3.5b37.5x46.1x13x
Price to Earnings Ratio

46.1x


Total Market Cap: kr.161.0bTotal Earnings: kr.3.5bTotal Revenue: kr.12.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 79.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 41.4x which is lower than its 3-year average PE of 79.9x.
  • The 3-year average PS ratio of 14.5x is higher than the industry's current PS ratio of 7.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 7.0% per year over the last three years.
  • Revenues for these companies have grown 23% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-0.004%
Healthcare0.42%
Biotech2.47%
Biotech2.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand Pharmakr.664.0040.4%
+kr.11.9b
193.5%PS120.4x
ORPHA Orphazymekr.1.27k5.4%
+kr.2.3m
59.3%PB1.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GMAB

kr.1,930.00

Genmab

7D

-3.4%

1Y

-24.6%

ZEAL

kr.664.00

Zealand Pharma

7D

40.4%

1Y

193.5%

ORPHA

kr.1,274.60

Orphazyme

7D

5.4%

1Y

59.3%

BIOPOR

kr.1.58

BioPorto

7D

-8.7%

1Y

-29.1%